Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis.

Publikation

Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis.

Wissenschaftlicher Artikel/Review - 03.06.2024

Bellomo Jacopo, Zeitlberger Anna Maria, Padevit Luis, Stumpo Vittorio, Gönel Meltem, Fierstra Jorn, Nierobisch Nathalie, Reimann Regina, Witzel Isabell, Weller Michael, Le Rhun Emilie, Bozinov Oliver, Regli Luca, Neidert Marian Christoph, Serra Carlo, Voglis Stefanos

Zitation

Bellomo J, Zeitlberger A, Padevit L, Stumpo V, Gönel M, Fierstra J, Nierobisch N, Reimann R, Witzel I, Weller M, Le Rhun E, Bozinov O, Regli L, Neidert M, Serra C, Voglis S. Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis. J Neurooncol 2024; 169:379-390.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

J Neurooncol 2024; 169

Veröffentlichungsdatum

03.06.2024

eISSN (Online)

1573-7373

Seiten

379-390

Kurzbeschreibung/Zielsetzung

Advancements in metastatic breast cancer (BC) treatment have enhanced overall survival (OS), leading to increased rates of brain metastases (BM). This study analyzes the association between microsurgical tumor reduction and OS in patients with BCBM, considering tumor molecular subtypes and perioperative treatment approaches.